Amalgamated Financial (AMAL) insider sells 5,242 shares; weighted avg ~$27.46
Rhea-AI Filing Summary
Amalgamated Financial Corp. insider Mandy Tenner, who is identified as the company's EVP and Chief Legal Officer, reported sales of common stock on 08/07/2025. The Form 4 shows two blocks sold: 1,576 shares and 3,666 shares, for a total of 5,242 shares disposed.
The filing reports weighted-average prices for the trades at approximately $27.4599 and $27.4583, with disclosed execution price ranges of $27.61–$27.33 and $27.59–$27.35. The reported beneficial ownership figures following the transactions include amounts shown as 16,577.24 and 12,911.24 shares, and the filings note that those totals incorporate 39 shares from the company ESPP and 17.24 shares from the dividend reimbursement plan.
Positive
- Transparent disclosure of weighted-average prices and execution ranges for the sales, with an undertaking to provide detailed per-price allocations on request
- Beneficial ownership totals are disclosed and explicitly note inclusion of 39 ESPP shares and 17.24 dividend-reimbursement shares, improving clarity
Negative
- Insider disposal of a total of 5,242 common shares (1,576 and 3,666 shares), which reduces the reporting person's direct holdings
- Sales occurred on 08/07/2025 at prices near $27.46, which investors may view as signaling liquidity needs or portfolio rebalancing
Insights
TL;DR: Executive sold 5,242 shares in two blocks at ~ $27.46; disclosure includes ESPP and dividend-plan shares in post-sale totals.
The sales are clearly disclosed and accompanied by weighted-average prices and execution ranges, which enhances transparency. The reporting person remains an officer and reports substantial residual holdings per the form. Because the filing includes specific price ranges and confirms availability of detailed allocation information on request, corporate governance standards for Section 16 disclosures are met.
TL;DR: Insider sales of 5,242 shares at roughly $27.46 reduce holdings but are routine based on the filing's footnotes.
The transaction sizes (1,576 and 3,666 shares) and reported weighted-average prices are explicit. Footnote detail that 39 ESPP shares and 17.24 dividend-reimbursement shares are included in reported totals helps clarify reported beneficial ownership. There is no additional context in the filing about intent or planned sales, so the market impact is likely limited absent other material disclosures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,576 | $27.4599 | $43K |
| Sale | Common Stock | 3,666 | $27.4583 | $101K |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.61 - $27.33. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. The total reported in Column 5 of this Form 4 includes 39 shares of common stock, acquired by the reporting person under the Company's employee stock purchase program, in Q1 of 2025, and 17.24 shares of common stock, acquired by the reporting person under the Company's dividend reimbursement plan, in Q2 of 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.59 - $27.35. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
